ONE DAY of respite
CAN ADD 23 DAYS
to the life of a caregiver.

EXPLORE OUR ADULT DAY CENTER

Medical Professionals

Caregivers

Volunteers

Join Us

Upcoming Events

December 2025
January 2026
Jan 06 2026
1:30 pm - 3:30 pm

Tuesday Tour

Adult Day Center
No event found!
Load More

OUR VISION: Creating a community where no one affected by Alzheimer’s or dementia makes the journey alone.

December 2025

January
MO
TU
WE
TH
FR
SA
SU
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

Caregiver Support Group: Brookdale

Caregiver Support Group: Brookdale
5:30 pm - 6:30 pm
Brookdale Senior Living  2540 Beene Blvd., Bossier City, LA 71111 318-747-2114 4th Thursday at 5:30 p.m. , ...
26
27
28
29
30
31
1

Caregiver Support Group: The Glen

Caregiver Support Group: The Glen
5:30 pm - 6:30 pm
The Glen 403 E. Flournoy Lucas Road, Shreveport, LA 71115 318-798-3500 1st Thursday at 5:30 p.m. , ...
2
3
4

CAREGIVER SERVICES

9

Caregiver Support Groups

9

Care Navigation with Care Plans

9

Professional Counseling

9

Care Coaching

9

Grandchildren’s Workshops & Counseling

9

System Navigation (Insurance, Legal, Housing Facilities)

9

Music & Art Programs

9

Respite Care (Adult Day Center)

“We have learned so much in our support group. I love caring for my wife but there’s so much to learn about Alzheimer’s disease and this is where I come with my questions.”

SUPPORT GROUP MEMBER

October 24th, 2025

Laura Gauthier Makes 2025 40 Under Forty List

Congratulations to our very own, Laura Gauthier, Assistant Executive Director, for making the 2025 Shreveport 40 Under Forty list! We are so proud of her dedication and the impact she makes each day at The Bridge.

View the full 40 Under Forty Class of 2025 HERE

Read More

October 22nd, 2025

New drug candidate targeting synaptic resilience well tolerated in Alzheimer’s patients

A small clinical trial suggests that a new type of drug may be safe for people with Alzheimer’s disease and could potentially mitigate some of the brain damage caused by the condition. Findings from the NIA-funded study, published in Nature Medicine, support further research to assess the drug’s long-term safety and...
Read More

October 22nd, 2025

New drug candidate targeting synaptic resilience well tolerated in Alzheimer’s patients

A small clinical trial suggests that a new type of drug may be safe for people with Alzheimer’s disease and could potentially mitigate some of the brain damage caused by the condition. Findings from the NIA-funded study, published in Nature Medicine, support further research to assess the drug’s long-term safety and...
Read More
View More